Cargando…

Beneficial Effects of Ipragliflozin on the Renal Function and Serum Uric Acid Levels in Japanese Patients with Type 2 Diabetes: A Randomized, 12-week, Open-label, Active-controlled Trial

OBJECTIVE: To examine the add-on effects, compared to the existing antidiabetes treatment, of the sodium-glucose cotransporter 2 inhibitor ipragliflozin on glycemic control and the risk factors of cardiovascular disease (CVD) and chronic kidney disease (CKD) in patients with inadequately controlled...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Masashi, Yamakage, Hajime, Inoue, Takayuki, Odori, Shinji, Kusakabe, Toru, Shimatsu, Akira, Satoh-Asahara, Noriko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086326/ https://www.ncbi.nlm.nih.gov/pubmed/32115517 http://dx.doi.org/10.2169/internalmedicine.3473-19

Ejemplares similares

Effects of dapagliflozin on the serum levels of fibroblast growth factor 21 and myokines and muscle mass in Japanese patients with type 2 diabetes: A randomized, controlled trial
por: Yamakage, Hajime, et al.
Publicado: (2019)

Oxytocin Suppresses Inflammatory Responses Induced by Lipopolysaccharide through Inhibition of the eIF-2α–ATF4 Pathway in Mouse Microglia
por: Inoue, Takayuki, et al.
Publicado: (2019)

Prediction of functional profiles of gut microbiota from 16S rRNA metagenomic data provides a more robust evaluation of gut dysbiosis occurring in Japanese type 2 diabetic patients
por: Inoue, Ryo, et al.
Publicado: (2017)

A combined index of waist circumference and muscle quality is associated with cardiovascular disease risk factor accumulation in Japanese obese patients: a cross-sectional study
por: Ikeue, Kentaro, et al.
Publicado: (2022)

Association between metabolic syndrome and multiple lesions of intracranial atherothrombotic stroke: a hospital-based study
por: Kotani, Kazuhiko, et al.
Publicado: (2015)

Visceral-to-subcutaneous fat ratio is a possible prognostic factor for type 1 endometrial cancer
por: Wada, Michiko, et al.
Publicado: (2021)

Differential effects of sodium-glucose cotransporter 2 inhibitor and low-carbohydrate diet on body composition and metabolic profile in obese diabetic db/db mice
por: Kusakabe, Toru, et al.
Publicado: (2020)

The effects of dietary instruction on cardiovascular risk markers after smoking cessation: study protocol for a multicenter randomized controlled trial in Japan
por: Komiyama, Maki, et al.
Publicado: (2018)

Hyperglycemia and Inflammatory Property of Circulating Monocytes are Associated with Inflammatory Property of Carotid Plaques in Patients Undergoing Carotid Endarterectomy
por: Tanaka, Masashi, et al.
Publicado: (2016)

Analysis of Factors That Determine Weight Gain during Smoking Cessation Therapy
por: Komiyama, Maki, et al.
Publicado: (2013)

Time-dependent Changes of Atherosclerotic LDL Complexes after Smoking Cessation
por: Komiyama, Maki, et al.
Publicado: (2016)

Analysis of changes on adiponectin levels and abdominal obesity after smoking cessation
por: Komiyama, Maki, et al.
Publicado: (2018)

Experimental Reproduction of Dynamic Fluctuation of TSH Receptor–Binding Antibodies Between Stimulation and Inhibition
por: Tagami, Tetsuya, et al.
Publicado: (2019)

Association between monocyte chemoattractant protein-1 and blood pressure in smokers
por: Komiyama, Maki, et al.
Publicado: (2017)

Short-term Changes in Self-rating Depression Scale Scores after Smoking Cessation in Neurotic Patients
por: Komiyama, Maki, et al.
Publicado: (2020)

Glycosuria medicated with ipragliflozin and nifedipine or ipragliflozin and candesartan: a case report
por: Okada, Shuichi, et al.
Publicado: (2014)

The effects of weight gain after smoking cessation on atherogenic α1-antitrypsin–low-density lipoprotein
por: Komiyama, Maki, et al.
Publicado: (2014)

Smoking cessation reduces the lectin-like low-density lipoprotein receptor index, an independent cardiovascular risk marker of vascular inflammation
por: Komiyama, Maki, et al.
Publicado: (2017)

Diagnostic accuracy of the anti‐glutamic acid decarboxylase antibody in type 1 diabetes mellitus: Comparison between radioimmunoassay and enzyme‐linked immunosorbent assay
por: Murata, Takashi, et al.
Publicado: (2017)

The Delayed Diagnosis of Thyroid Storm in Patients with Psychosis
por: Ishihara, Yuki, et al.
Publicado: (2019)

Long-Term Effects of Ipragliflozin on Diabetic Nephropathy and Blood Pressure in Patients With Type 2 Diabetes: 104-Week Follow-up of an Open-Label Study
por: Ito, Daisuke, et al.
Publicado: (2018)

Association of protein tyrosine phosphatase 1B gene polymorphism with the effects of weight reduction therapy on bodyweight and glycolipid profiles in obese patients
por: Yamakage, Hajime, et al.
Publicado: (2021)

Response to Comment on: Satoh-Asahara et al. Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia. Diabetes Care 2012;35:2631–2639
por: Satoh-Asahara, Noriko, et al.
Publicado: (2013)

Analysis of time-dependent changes in the FIB4 index in patients with obesity receiving weight reduction therapy
por: Kawai, Shiori, et al.
Publicado: (2022)

Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives
por: Tanaka, Masashi, et al.
Publicado: (2019)

Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer’s Disease
por: Tanaka, Masashi, et al.
Publicado: (2020)

Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study
por: Iizuka, Takashi, et al.
Publicado: (2016)

Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer
por: Ikeda, Asami, et al.
Publicado: (2020)

Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study
por: Ishihara, Hisamitsu, et al.
Publicado: (2018)

Effects of Ipragliflozin on Diabetic Nephropathy and Blood Pressure in Patients With Type 2 Diabetes: An Open-Label Study
por: Ito, Daisuke, et al.
Publicado: (2017)

Correction: Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study
por: Iizuka, Takashi, et al.
Publicado: (2016)

A Patient-Held Medical Record Integrating Depression Care into Diabetes Care
por: Satoh-Asahara, Noriko, et al.
Publicado: (2016)

Effects of Metformin on Left Ventricular Size and Function in Hypertensive Patients with Type 2 Diabetes Mellitus: Results of a Randomized, Controlled, Multicenter, Phase IV Trial
por: Ono, Koh, et al.
Publicado: (2019)

Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes and inadequate glycaemic control on sitagliptin
por: Kaku, Kohei, et al.
Publicado: (2021)

Psychological Effects of Aromatherapy on Smokers With Depressive Tendencies During Smoking Cessation Treatment: Protocol for a Pre-Post Single-Arm Clinical Trial
por: Hata, Akiko, et al.
Publicado: (2022)

Cystatin C‐based eGFR predicts cardiovascular disease in patients with overweight/obesity and hyperglycemia
por: Suzuki, Keita, et al.
Publicado: (2022)

Taxifolin Suppresses Inflammatory Responses of High-Glucose-Stimulated Mouse Microglia by Attenuating the TXNIP–NLRP3 Axis
por: Iwasa, Masayo, et al.
Publicado: (2023)

Long‐term (52‐week) efficacy and safety of ipragliflozin add‐on therapy to insulin in Japanese patients with type 1 diabetes mellitus: An uncontrolled, open‐label extension of a phase III study
por: Kaku, Kohei, et al.
Publicado: (2020)

Comprehensive renoprotective effects of ipragliflozin on early diabetic nephropathy in mice
por: Kamezaki, Michitsugu, et al.
Publicado: (2018)

Distinct Characteristics of VEGF‐D and VEGF‐C to Predict Mortality in Patients With Suspected or Known Coronary Artery Disease
por: Wada, Hiromichi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dsr1kvnbc8jct97buu41s4idkk